About Index Trending news
Analyze
Pricing
AVROBIO

AVROBIO

Work at AVROBIO? Add yourself to this profile

AVROBIO

Clinical stage company developing step-change cell and gene therapies targeting cancer and rare disease.
Edit Profile
More info

Elsewhere

Also headquartered in Boston

DraftKings DraftKings General Electric General Electric Wikibon Wikibon Zipcar Zipcar Bain Capital Bain Capital Bolt Bolt Runkeeper Runkeeper MassChallenge MassChallenge The Boston Globe The Boston Globe Battery Ventures Battery Ventures

Companies in the same industry

23andMe 23andMe Blue Belt Technologies Blue Belt Technologies Health IQ Health IQ Adaptive Biotech Adaptive Biotech Gecko Biomedical Gecko Biomedical Eccrine Systems Eccrine Systems NuSirt Sciences, Inc NuSirt Sciences, Inc Synchro PET Synchro PET Inspyr Inspyr Essia Health Essia Health

Alexa global traffic share

Twitter followers

Terms of Service API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2017
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Funding 1
Add info
02 Aug 2016
$25,000,000
Venture capital (Series A)
Atlas Venture, SV Life Sciences, Clarus

AVROBIO, Inc. Announces $25 Million Series A Financing to Advance Novel, Clinical-Stage Gene Therapies for Rare Diseases and Cancer | Business Wire

businesswire